Variation in Microbiome LPS Immunogenicity Contributes to Autoimmunity in Humans
2016; Cell Press; Volume: 165; Issue: 6 Linguagem: Inglês
10.1016/j.cell.2016.05.056
ISSN1097-4172
AutoresTommi Vatanen, Aleksandar D. Kostic, Eva d’Hennezel, Heli Siljander, Eric A. Franzosa, Moran Yassour, Raivo Kolde, Hera Vlamakis, Timothy D. Arthur, Anu‐Maaria Hämäläinen, Aleksandr Peet, Vallo Tillmann, Raivo Uibo, Sergei Mokurov, Н В Доршакова, Jorma Ilonen, Suvi Μ. Virtanen, Susanne J. Szabo, Jeffrey A. Porter, Harri Lähdesmäki, Curtis Huttenhower, Dirk Gevers, Thomas W. Cullen, Mikael Knip, Ramnik J. Xavier,
Tópico(s)Infant Nutrition and Health
Resumo(Cell 165, 842–853; May 5, 2016) In the above article, the originally published Table S1 contained information that was not compatible with our Institutional Review Board (IRB) protocol. We overlooked this when finalizing the paper for publication and detected the issue only after publication online. Table S1 has now been replaced online with a version that is in compliance. The changes in the table do not affect the conclusions of the paper. We acknowledge the serious nature of this oversight and sincerely apologize for the error. Variation in Microbiome LPS Immunogenicity Contributes to Autoimmunity in HumansVatanen et al.CellApril 28, 2016In BriefBacteroides species in the microbiota of children from countries with high susceptibility to autoimmunity produce a type of lipopolysaccharide (LPS) with immunoinhibitory properties. These properties may preclude early immune education and contribute to the development of type 1 diabetes. Full-Text PDF Open Archive
Referência(s)